lung-cancer

Gene BDH2 suppresses lung cancer spread by triggering iron-dependent cell death.

BDH2 overexpression in LUAD cell lines and xenograft mice significantly inhibited migration, invasion, and metastasis. Mechanism: BDH2 suppresses the Nrf2/HO-1 ferroptosis-resistance pathway, enhancing cancer cell sensitivity to ferroptotic death. Ferroptosis inhibitor Fer-1 reversed these effects,…

Gene BDH2 suppresses lung cancer spread by triggering iron-dependent cell death.

Key Findings

BDH2 overexpression inhibited LUAD cell migration and invasion in vitro
In vivo: BDH2 reduced tumor growth and metastasis in xenograft mice
BDH2 suppresses Nrf2/HO-1 pathway, enhancing ferroptosis sensitivity
Ferroptosis inhibitor Fer-1 reversed anti-metastatic effects
BDH2 identified as a potential therapeutic target for LUAD

Implications

BDH2-mediated ferroptosis represents a new avenue for metastatic LUAD treatment. Drugs enhancing BDH2 activity or activating ferroptosis independently could be combined with existing therapies.

Caveats

Preclinical cell line and xenograft study; abstract-only. Nrf2/HO-1 inhibition has broad cellular effects. Significant translational gap.

Source: Archivum immunologiae et therapiae experimentalis — 2026-01-01

Landmark DCIS trial, CRC microbiome & AML combos

Two themes cut across this week’s 236 posts. The first is de-escalation: researchers are building rigorous evidence that patients can safely do less — skip lymph node surgery, forgo radiotherapy, watch pre-invasive lesions instead of cutting them out. The landmark result here is a randomized trial confirming that active surveillance

Colorectal Cancer Microbiome Discovery Platform

Analysis of 9,000+ patients revealed that only colorectal cancer — not other cancer types — consistently harbors distinct microbial communities, suggesting the gut microbiome has a unique relationship with colorectal carcinogenesis that could be exploited for diagnostics and treatment.

GBM Tumor Microenvironment Drug Target Atlas

Non-cancerous brain support cells were found to promote glioblastoma growth through paracrine signaling, and blocking this communication dramatically slowed tumor growth — revealing that GBM's microenvironment contains targetable vulnerabilities that are being systematically overlooked by drug…

BET Inhibitor Target Selectivity Database

BRD2 and BRD4 have fundamentally distinct functions — BRD2 prepares genes for activation while BRD4 triggers transcription — meaning that pan-BET inhibitors have been disrupting gene regulation in counterproductive ways, and the field now needs selective BRD4 inhibitors.

Gene BDH2 suppresses lung cancer spread by triggering iron-dependent cell death.

Key Findings

Implications

Caveats

Read more

Landmark DCIS trial, CRC microbiome & AML combos

Colorectal Cancer Microbiome Discovery Platform

GBM Tumor Microenvironment Drug Target Atlas

BET Inhibitor Target Selectivity Database